1. Home
  2. RVPH vs CRWS Comparison

RVPH vs CRWS Comparison

Compare RVPH & CRWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • CRWS
  • Stock Information
  • Founded
  • RVPH 2006
  • CRWS 1957
  • Country
  • RVPH United States
  • CRWS United States
  • Employees
  • RVPH N/A
  • CRWS N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • CRWS Textiles
  • Sector
  • RVPH Health Care
  • CRWS Consumer Discretionary
  • Exchange
  • RVPH Nasdaq
  • CRWS Nasdaq
  • Market Cap
  • RVPH 32.8M
  • CRWS 34.0M
  • IPO Year
  • RVPH N/A
  • CRWS N/A
  • Fundamental
  • Price
  • RVPH $0.37
  • CRWS $2.92
  • Analyst Decision
  • RVPH Strong Buy
  • CRWS
  • Analyst Count
  • RVPH 5
  • CRWS 0
  • Target Price
  • RVPH $9.00
  • CRWS N/A
  • AVG Volume (30 Days)
  • RVPH 2.6M
  • CRWS 53.1K
  • Earning Date
  • RVPH 08-13-2025
  • CRWS 08-13-2025
  • Dividend Yield
  • RVPH N/A
  • CRWS 10.85%
  • EPS Growth
  • RVPH N/A
  • CRWS N/A
  • EPS
  • RVPH N/A
  • CRWS N/A
  • Revenue
  • RVPH N/A
  • CRWS $87,250,000.00
  • Revenue This Year
  • RVPH N/A
  • CRWS N/A
  • Revenue Next Year
  • RVPH N/A
  • CRWS N/A
  • P/E Ratio
  • RVPH N/A
  • CRWS N/A
  • Revenue Growth
  • RVPH N/A
  • CRWS N/A
  • 52 Week Low
  • RVPH $0.30
  • CRWS $2.76
  • 52 Week High
  • RVPH $4.28
  • CRWS $5.18
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 30.28
  • CRWS 45.77
  • Support Level
  • RVPH $0.35
  • CRWS $2.76
  • Resistance Level
  • RVPH $0.83
  • CRWS $3.00
  • Average True Range (ATR)
  • RVPH 0.07
  • CRWS 0.13
  • MACD
  • RVPH -0.04
  • CRWS -0.01
  • Stochastic Oscillator
  • RVPH 11.32
  • CRWS 41.30

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

Share on Social Networks: